img

Global Opioids Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Opioids Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Opioids report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Opioids market is projected to reach US$ 14730 million in 2034, increasing from US$ 10050 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2034. Demand from Pain Relief and Anesthesia are the major drivers for the industry.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other

Segment by Application


Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Opioids market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Opioids, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Opioids industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Opioids in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Opioids introduction, etc. Opioids Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Opioids market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Opioids Market Overview
1.1 Opioids Product Overview
1.2 Opioids Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Global Opioids Market Size by Type
1.3.1 Global Opioids Market Size Overview by Type (2018-2034)
1.3.2 Global Opioids Historic Market Size Review by Type (2018-2024)
1.3.3 Global Opioids Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Sales Breakdown by Type (2018-2024)
1.4.2 Europe Opioids Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Opioids Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Opioids Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Opioids Sales Breakdown by Type (2018-2024)
2 Global Opioids Market Competition by Company
2.1 Global Top Players by Opioids Sales (2018-2024)
2.2 Global Top Players by Opioids Revenue (2018-2024)
2.3 Global Top Players by Opioids Price (2018-2024)
2.4 Global Top Manufacturers Opioids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2022)
2.7 Date of Key Manufacturers Enter into Opioids Market
2.8 Key Manufacturers Opioids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Status and Outlook by Region
3.1 Global Opioids Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Opioids Historic Market Size by Region
3.2.1 Global Opioids Sales in Volume by Region (2018-2024)
3.2.2 Global Opioids Sales in Value by Region (2018-2024)
3.2.3 Global Opioids Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Opioids Forecasted Market Size by Region
3.3.1 Global Opioids Sales in Volume by Region (2024-2034)
3.3.2 Global Opioids Sales in Value by Region (2024-2034)
3.3.3 Global Opioids Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Opioids by Application
4.1 Opioids Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Cough Suppression
4.1.4 Diarrhea Suppression
4.1.5 Deaddiction
4.1.6 Others
4.2 Global Opioids Market Size by Application
4.2.1 Global Opioids Market Size Overview by Application (2018-2034)
4.2.2 Global Opioids Historic Market Size Review by Application (2018-2024)
4.2.3 Global Opioids Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Sales Breakdown by Application (2018-2024)
4.3.2 Europe Opioids Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Opioids Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Opioids Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Opioids Sales Breakdown by Application (2018-2024)
5 North America Opioids by Country
5.1 North America Opioids Historic Market Size by Country
5.1.1 North America Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Opioids Sales in Volume by Country (2018-2024)
5.1.3 North America Opioids Sales in Value by Country (2018-2024)
5.2 North America Opioids Forecasted Market Size by Country
5.2.1 North America Opioids Sales in Volume by Country (2024-2034)
5.2.2 North America Opioids Sales in Value by Country (2024-2034)
6 Europe Opioids by Country
6.1 Europe Opioids Historic Market Size by Country
6.1.1 Europe Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Opioids Sales in Volume by Country (2018-2024)
6.1.3 Europe Opioids Sales in Value by Country (2018-2024)
6.2 Europe Opioids Forecasted Market Size by Country
6.2.1 Europe Opioids Sales in Volume by Country (2024-2034)
6.2.2 Europe Opioids Sales in Value by Country (2024-2034)
7 Asia-Pacific Opioids by Region
7.1 Asia-Pacific Opioids Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Opioids Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Opioids Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Opioids Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Opioids Sales in Value by Region (2024-2034)
8 Latin America Opioids by Country
8.1 Latin America Opioids Historic Market Size by Country
8.1.1 Latin America Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Opioids Sales in Volume by Country (2018-2024)
8.1.3 Latin America Opioids Sales in Value by Country (2018-2024)
8.2 Latin America Opioids Forecasted Market Size by Country
8.2.1 Latin America Opioids Sales in Volume by Country (2024-2034)
8.2.2 Latin America Opioids Sales in Value by Country (2024-2034)
9 Middle East and Africa Opioids by Country
9.1 Middle East and Africa Opioids Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Opioids Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Opioids Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Opioids Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Opioids Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Teva Opioids Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Company Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Purdue Pharma Opioids Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mallinckrodt Opioids Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Company Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amneal Pharma Opioids Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Company Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Collegium Opioids Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Company Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Sales, Revenue and Gross Margin (2018-2024)
10.6.4 J&J Opioids Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Company Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Endo Opioids Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Opioids Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Company Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2018-2024)
10.9.4 INSYS Opioids Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan Opioids Products Offered
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Company Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hikma Opioids Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Company Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Egalet Opioids Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Industrial Chain Analysis
11.4 Opioids Market Dynamics
11.4.1 Opioids Industry Trends
11.4.2 Opioids Market Drivers
11.4.3 Opioids Market Challenges
11.4.4 Opioids Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Distributors
12.3 Opioids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oxycodone
Table 2. Major Company of Hydromorphone
Table 3. Major Company of Codeine
Table 4. Major Company of Fentanyl
Table 5. Major Company of Other
Table 6. Global Opioids Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Opioids Sales by Type (2018-2024) & (MT)
Table 8. Global Opioids Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Opioids Sales by Type (2018-2024) & (US& Million)
Table 10. Global Opioids Market Share in Value by Type (2018-2024)
Table 11. Global Opioids Price by Type (2018-2024) & (USD/Kg)
Table 12. Global Opioids Sales by Type (2024-2034) & (MT)
Table 13. Global Opioids Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Opioids Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Opioids Sales Market Share in Value by Type (2024-2034)
Table 16. Global Opioids Price by Type (2024-2034) & (USD/Kg)
Table 17. North America Opioids Sales by Type (2018-2024) & (MT)
Table 18. North America Opioids Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Opioids Sales (MT) by Type (2018-2024)
Table 20. Europe Opioids Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Opioids Sales (MT) by Type (2018-2024)
Table 22. Asia-Pacific Opioids Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Opioids Sales (MT) by Type (2018-2024)
Table 24. Latin America Opioids Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Opioids Sales (MT) by Type (2018-2024)
Table 26. Middle East and Africa Opioids Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Opioids Sales by Company (2018-2024) & (MT)
Table 28. Global Opioids Sales Share by Company (2018-2024)
Table 29. Global Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Opioids Revenue Share by Company (2018-2024)
Table 31. Global Market Opioids Price by Company (2018-2024) & (USD/Kg)
Table 32. Global Opioids Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2022)
Table 35. Date of Key Manufacturers Enter into Opioids Market
Table 36. Key Manufacturers Opioids Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Opioids Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Opioids Sales by Region (2018-2024) & (MT)
Table 40. Global Opioids Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Opioids Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Opioids Sales Market Share in Value by Region (2018-2024)
Table 43. Global Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 44. Global Opioids Sales by Region (2024-2034) & (MT)
Table 45. Global Opioids Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Opioids Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Opioids Sales Market Share in Value by Region (2024-2034)
Table 48. Global Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 49. Global Opioids Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Opioids Sales by Application (2018-2024) & (MT)
Table 51. Global Opioids Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Opioids Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Opioids Sales Market Share in Value by Application (2018-2024)
Table 54. Global Opioids Price by Application (2018-2024) & (USD/Kg)
Table 55. Global Opioids Sales by Application (2024-2034) & (MT)
Table 56. Global Opioids Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Opioids Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Opioids Sales Market Share in Value by Application (2024-2034)
Table 59. Global Opioids Price by Application (2024-2034) & (USD/Kg)
Table 60. North America Opioids Sales by Application (2018-2024) (MT)
Table 61. North America Opioids Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Opioids Sales by Application (2018-2024) (MT)
Table 63. Europe Opioids Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Opioids Sales by Application (2018-2024) (MT)
Table 65. Asia-Pacific Opioids Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Opioids Sales by Application (2018-2024) (MT)
Table 67. Latin America Opioids Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Opioids Sales by Application (2018-2024) (MT)
Table 69. Middle East and Africa Opioids Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Opioids Sales by Country (2018-2024) & (MT)
Table 71. North America Opioids Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Opioids Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Opioids Sales Market Share in Value by Country (2018-2024)
Table 74. North America Opioids Sales by Country (2024-2034) & (MT)
Table 75. North America Opioids Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Opioids Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Opioids Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Opioids Sales by Country (2018-2024) & (MT)
Table 79. Europe Opioids Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Opioids Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Opioids Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Opioids Sales by Country (2024-2034) & (MT)
Table 83. Europe Opioids Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Opioids Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Opioids Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Opioids Sales by Region (2018-2024) & (MT)
Table 87. Asia-Pacific Opioids Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Opioids Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Opioids Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Opioids Sales by Region (2024-2034) & (MT)
Table 91. Asia-Pacific Opioids Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Opioids Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Opioids Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Opioids Sales by Country (2018-2024) & (MT)
Table 95. Latin America Opioids Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Opioids Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Opioids Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Opioids Sales by Country (2024-2034) & (MT)
Table 99. Latin America Opioids Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Opioids Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Opioids Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Opioids Sales by Country (2018-2024) & (MT)
Table 103. Middle East and Africa Opioids Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Opioids Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Opioids Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Opioids Sales by Country (2024-2034) & (MT)
Table 107. Middle East and Africa Opioids Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Opioids Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Opioids Sales Market Share in Value by Country (2024-2034)
Table 110. Teva Company Information
Table 111. Teva Introduction and Business Overview
Table 112. Teva Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 113. Teva Opioids Product
Table 114. Teva Recent Development
Table 115. Purdue Pharma Company Information
Table 116. Purdue Pharma Introduction and Business Overview
Table 117. Purdue Pharma Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 118. Purdue Pharma Opioids Product
Table 119. Purdue Pharma Recent Development
Table 120. Mallinckrodt Company Information
Table 121. Mallinckrodt Introduction and Business Overview
Table 122. Mallinckrodt Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 123. Mallinckrodt Opioids Product
Table 124. Mallinckrodt Recent Development
Table 125. Amneal Pharma Company Information
Table 126. Amneal Pharma Introduction and Business Overview
Table 127. Amneal Pharma Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 128. Amneal Pharma Opioids Product
Table 129. Amneal Pharma Recent Development
Table 130. Collegium Company Information
Table 131. Collegium Introduction and Business Overview
Table 132. Collegium Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 133. Collegium Opioids Product
Table 134. Collegium Recent Development
Table 135. J&J Company Information
Table 136. J&J Introduction and Business Overview
Table 137. J&J Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 138. J&J Opioids Product
Table 139. J&J Recent Development
Table 140. Endo Company Information
Table 141. Endo Introduction and Business Overview
Table 142. Endo Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 143. Endo Opioids Product
Table 144. Endo Recent Development
Table 145. Pfizer Company Information
Table 146. Pfizer Introduction and Business Overview
Table 147. Pfizer Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 148. Pfizer Opioids Product
Table 149. Pfizer Recent Development
Table 150. INSYS Company Information
Table 151. INSYS Introduction and Business Overview
Table 152. INSYS Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 153. INSYS Opioids Product
Table 154. INSYS Recent Development
Table 155. Mylan Company Information
Table 156. Mylan Introduction and Business Overview
Table 157. Mylan Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 158. Mylan Opioids Product
Table 159. Mylan Recent Development
Table 160. Hikma Company Information
Table 161. Hikma Introduction and Business Overview
Table 162. Hikma Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 163. Hikma Opioids Product
Table 164. Hikma Recent Development
Table 165. Egalet Company Information
Table 166. Egalet Introduction and Business Overview
Table 167. Egalet Opioids Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 168. Egalet Opioids Product
Table 169. Egalet Recent Development
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Opioids Market Trends
Table 173. Opioids Market Drivers
Table 174. Opioids Market Challenges
Table 175. Opioids Market Restraints
Table 176. Opioids Distributors List
Table 177. Opioids Downstream Customers
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Global Opioids Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Opioids Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Opioids Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Oxycodone
Figure 6. Global Oxycodone Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Hydromorphone
Figure 8. Global Hydromorphone Sales YoY Growth (2018-2034) & (MT)
Figure 9. Product Picture of Codeine
Figure 10. Global Codeine Sales YoY Growth (2018-2034) & (MT)
Figure 11. Product Picture of Fentanyl
Figure 12. Global Fentanyl Sales YoY Growth (2018-2034) & (MT)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2018-2034) & (MT)
Figure 15. Global Opioids Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Opioids Sales Market Share by Type in 2022 & 2034
Figure 17. North America Opioids Sales Market Share in Volume by Type in 2022
Figure 18. North America Opioids Sales Market Share in Value by Type in 2022
Figure 19. Europe Opioids Sales Market Share in Volume by Type in 2022
Figure 20. Europe Opioids Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Opioids Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Opioids Sales Market Share in Value by Type in 2022
Figure 23. Latin America Opioids Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Opioids Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Opioids Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Opioids Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Revenue in 2022
Figure 29. Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Pain Relief
Figure 31. Global Pain Relief Sales YoY Growth (2018-2034) & (MT)
Figure 32. Product Picture of Anesthesia
Figure 33. Global Anesthesia Sales YoY Growth (2018-2034) & (MT)
Figure 34. Product Picture of Cough Suppression
Figure 35. Global Cough Suppression Sales YoY Growth (2018-2034) & (MT)
Figure 36. Product Picture of Diarrhea Suppression
Figure 37. Global Diarrhea Suppression Sales YoY Growth (2018-2034) & (MT)
Figure 38. Product Picture of Deaddiction
Figure 39. Global Deaddiction Sales YoY Growth (2018-2034) & (MT)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (MT)
Figure 42. Global Opioids Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Opioids Sales Market Share by Application in 2022 & 2034
Figure 44. North America Opioids Sales Market Share in Volume by Application in 2022
Figure 45. North America Opioids Sales Market Share in Value by Application in 2022
Figure 46. Europe Opioids Sales Market Share in Volume by Application in 2022
Figure 47. Europe Opioids Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Opioids Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Opioids Sales Market Share in Value by Application in 2022
Figure 50. Latin America Opioids Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Opioids Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Opioids Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Opioids Manufacturing Cost Structure
Figure 55. Opioids Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries